Chemoinformaics analysis of Anhydrofurospongin-1
| Molecular Weight | 312.453 | nRot | 10 |
| Heavy Atom Molecular Weight | 284.229 | nRig | 12 |
| Exact Molecular Weight | 312.209 | nRing | 2 |
| Solubility: LogS | -5.477 | nHRing | 2 |
| Solubility: LogP | 7.233 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 10 |
| nHA | 2 | APOL | 55.3442 |
| nHD | 0 | BPOL | 31.5618 |
| QED | 0.468 |
| Synth | 2.955 |
| Natural Product Likeliness | 1.469 |
| NR-PPAR-gamma | 0.239 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.998 |
| Pgp-sub | 0.706 |
| HIA | 0.005 |
| CACO-2 | -4.558 |
| MDCK | 0.0000184 |
| BBB | 0.035 |
| PPB | 0.955023 |
| VDSS | 4.933 |
| FU | 0.0403634 |
| CYP1A2-inh | 0.954 |
| CYP1A2-sub | 0.158 |
| CYP2c19-inh | 0.818 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.761 |
| CYP2c9-sub | 0.182 |
| CYP2d6-inh | 0.734 |
| CYP2d6-sub | 0.241 |
| CYP3a4-inh | 0.77 |
| CYP3a4-sub | 0.184 |
| CL | 12.045 |
| T12 | 0.198 |
| hERG | 0.131 |
| Ames | 0.007 |
| ROA | 0.981 |
| SkinSen | 0.046 |
| Carcinogencity | 0.763 |
| EI | 0.446 |
| Respiratory | 0.814 |
| NR-Aromatase | 0.021 |
| Antiviral | No |
| Prediction | 0.636118 |